FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

8265011000001107: Moxonidine 300microgram tablets (Alpharma Limited) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21225901000001114 Moxonidine 300microgram tablets (Alpharma Limited) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
39254501000001113 Moxonidine 300microgram tablets (Actavis UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Moxonidine 300microgram tablets (Alpharma Limited) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Moxonidine 300microgram tablets (Alpharma Limited) Is a Product containing precisely moxonidine 300 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Moxonidine 300microgram tablets (Alpharma Limited) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Moxonidine 300microgram tablets (Alpharma Limited) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Moxonidine 300microgram tablets (Alpharma Limited) Has active ingredient Moxonidine false Inferred relationship Existential restriction modifier
Moxonidine 300microgram tablets (Alpharma Limited) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Moxonidine 300microgram tablets (Alpharma Limited) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Moxonidine 300microgram tablets (Alpharma Limited) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Moxonidine 300microgram tablets (Alpharma Limited) Has specific active ingredient Moxonidine true Inferred relationship Existential restriction modifier
Moxonidine 300microgram tablets (Alpharma Limited) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Moxonidine 300microgram tablets (Alpharma Limited) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Moxonidine 300microgram tablets (Alpharma Limited) Has excipient Lactose false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Moxonidine 300microgram tablets (Alpharma Limited) 28 tablet 2 x 14 tablets Is pack of False Moxonidine 300microgram tablets (Alpharma Limited) Inferred relationship Existential restriction modifier
Moxonidine 300microgram tablets (Alpharma Limited) 28 tablet 2 x 14 tablets Has AMP True Moxonidine 300microgram tablets (Alpharma Limited) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start